---
schema_version: "secwatch.filing_event.v1"
accession: "0001555280-26-000021"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:40:29.370995+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Zoetis Q1 revenue flat organic; cuts FY 2026 guidance on softer demand and competition

## Summary
- Revenue $2.3B, +3% reported but flat organic; net income $601M ($1.42 EPS), flat YoY.
- Adjusted net income $646M ($1.53 EPS), +2% reported, +1% organic; guidance cut: FY rev $9.68-9.96B (2-5% organic growth).
- U.S. segment revenue down 8% on competitive pressure and macro price sensitivity; International up 10% organic.
- Acquisition of Neogen animal genomics business announced March 2, expected to close H2 2026.
- Pipeline includes >12 potential blockbusters; recent approvals in Canada, Thailand, Japan.

## SEC filing metadata
- accession: 0001555280-26-000021
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000021/0001555280-26-000021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000021/zts-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001555280-26-000021
- JSON: https://secwatch.observer/filing/0001555280-26-000021.json
- Plain text: https://secwatch.observer/filing/0001555280-26-000021.txt

## Key facts
- Earnings Releases
  Zoetis Inc. reported full year 2026 results: revenue $9.680 - $9.960 Billion, EPS $6.85 to $7.00.
  - Period: full year 2026
  - Revenue: $9.680 - $9.960 Billion
  - EPS: $6.85 to $7.00
  - Result: guidance update
  source text: Revises Full Year 2026 Revenue Guidance to $9.680 - $9.960 Billion with Organic Operational Revenue Growth of 2% to 5% • Revises Full Year 2026 Guidance for Organic Operational Growth in Adjusted Net Income to 2% to 6% • Revises Guidance for Diluted EPS on an Adjusted Basis to $6.85 to $7.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000021/0001555280-26-000021-index.htm
- Earnings Releases
  Zoetis Inc. reported Q1 2026 results: revenue $2.3 Billion, net income $601 million, EPS $1.42 per diluted share.
  - Period: Q1 2026
  - Revenue: $2.3 Billion
  - Net income: $601 million
  - EPS: $1.42 per diluted share
  - Result: reported results
  source text: Zoetis Announces First Quarter 2026 Results • Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis • Adjusted Net Income of $646 Million, or Adjusted Diluted EPS of $1.53
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000155528026000021/0001555280-26-000021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.